Related Experiment Video
Updated: Feb 23, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Candida auris: An emerging multidrug-resistant pathogen
David Sears1, Brian S Schwartz1
1Division of Infectious Diseases, University of California, San Francisco, USA.
Abstract:
Candida aurisis an emerging multidrug-resistant pathogen that can be difficult to identify using traditional biochemical methods. C. auris is capable of causing invasive fungal infections, particularly among hospitalized patients with significant medical comorbidities. Echinocandins are the empiric drugs of choice for C. auris, although not all isolates are susceptible and resistance may develop on therapy. Nosocomial C. auris outbreaks have been reported in a number of countries and aggressive infection control measures are paramount to stopping transmission.
Insights
Candida auris is a difficult-to-identify, multidrug-resistant fungus causing invasive infections in hospitalized patients. Aggressive infection control is crucial to prevent the spread of this emerging pathogen.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Candida auris is an emerging multidrug-resistant fungal pathogen.
- It poses a significant threat, causing invasive infections in hospitalized individuals with comorbidities.
- Traditional identification methods can be challenging for C. auris.
Purpose of the Study:
- To highlight the challenges in identifying and treating Candida auris infections.
- To emphasize the importance of infection control measures against C. auris outbreaks.
- To discuss the role of echinocandins in C. auris treatment and the emergence of resistance.
Main Methods:
- Review of current literature on Candida auris.
- Analysis of diagnostic challenges.
- Assessment of treatment strategies and resistance patterns.
Main Results:
- Candida auris exhibits multidrug resistance, complicating treatment options.
- Echinocandins are primary treatments, but resistance can occur.
- Nosocomial outbreaks of C. auris have been documented globally.
Conclusions:
- Effective identification and treatment of C. auris are critical.
- Antifungal resistance in C. auris necessitates vigilant monitoring.
- Strict infection control protocols are essential to curb transmission and outbreaks.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Fungal Phylum Ascomycota

